Related Experiment Videos
Compliance with antihypertensive treatment
1Clinica Medica III, Policlinico S.Orsola, Università di Bologna, Italy.
Insights
Patient adherence to high blood pressure medication is crucial for treatment success. Physicians play a key role by providing clear information and simple treatment plans to improve patient compliance.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Antihypertensive treatment compliance is vital for successful therapy outcomes.
- Patient adherence rates vary significantly (20-80%) based on monitoring methods.
- Historically, compliance was viewed as solely a patient issue, but physician influence is now recognized.
Purpose of the Study:
- To highlight the critical role of physicians in improving patient compliance with antihypertensive treatments.
- To emphasize the need for clear patient communication regarding disease risks and therapy benefits.
- To advocate for simplified therapeutic regimens and proactive monitoring of high-risk patients.
Main Methods:
- Review of existing literature on patient compliance in hypertension management.
- Analysis of factors influencing adherence, including physician communication and treatment complexity.
- Identification of patient subgroups at higher risk for non-compliance.
Main Results:
- Physician actions, such as clear information delivery and simplified prescribing, significantly impact compliance.
- Specific patient demographics (e.g., middle-aged, working males without prior cardiovascular disease) require targeted monitoring.
- Poor therapeutic response should prompt suspicion of non-compliance.
Conclusions:
- Physician-patient communication and treatment simplification are essential for enhancing antihypertensive medication adherence.
- Standardized methods for assessing compliance are necessary, particularly in clinical trials, to ensure reliable data.
- Recognizing and addressing physician-influenced factors can improve treatment efficacy and patient outcomes.
Abstract:
Compliance to antihypertensive treatment is a critical factor conditioning the success of therapy. It has been calculated that, depending on the method used to monitor compliance, only 20 to 80% of treated hypertensives can be considered as good compliers. In the past years it was thought that compliance was only a patient's problem but instead, the role of the physician in determining patient's compliance is very important. He should give clear information about the risks of the disease, the advantages of therapy and how to take medicines. He should also prescribe a therapeutic scheme as simple as possible avoiding multiple drug administrations and informing patients about possible side-effects. Subjects at particular risk of poor compliance (middle aged males, still active in work, without previous cardiovascular diseases) must be particularly monitored. In any case of poor response to therapy it is important to suspect poor compliance. A standardization of the methods for recording compliance is needed especially in clinical trials. The results of experimental studies in fact can be misleading if compliance is not taken into account.